Tadalafil's Vasodilatory Effects

Mechanism of Action

• The American College of Cardiology notes that tadalafil inhibits PDE5, which normally hydrolyzes cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and vasodilation 1
• By preventing cGMP degradation, tadalafil enhances and prolongs the vasodilating effects of nitric oxide, according to the American College of Cardiology 1
• This vasodilation effect is the primary mechanism for its therapeutic benefits in both erectile dysfunction and pulmonary hypertension, as reported by the American College of Cardiology 1, 2

Vasodilatory Applications

• Tadalafil's vasodilatory properties make it effective for treating erectile dysfunction by increasing blood flow to the penis, as noted in research published in Diabetes/Metabolism Research and Reviews 3
• The American College of Cardiology reports that tadalafil was being studied for pulmonary arterial hypertension (PAH) treatment as of 2009 due to its vasodilatory effects 2

Systemic Vasodilatory Effects of Tadalafil

Clinical Evidence and Therapeutic Applications

• The American College of Cardiology and European Society of Cardiology both classify PDE5 inhibitors, including tadalafil, as vasodilators that cause pulmonary vasodilation and have been studied for pulmonary arterial hypertension 4, 5, 6
• Tadalafil is FDA-approved for pulmonary arterial hypertension, where its vasodilatory effects on pulmonary vasculature improve exercise capacity and hemodynamics 5

Mechanism of Action and Safety Implications

• No cited facts are available for this section